Lipid Panel Test Market
Geographically North America dominated global lipid panel test market driven by best in the class healthcare infrastructure, advanced facilities and awareness and openness amongst citizens towards the availability of the treatment and higher spending by citizens on the healthcare. North America was followed by Europe and Asia-Pacific as second and third largest market for lipid panel test market. Asia Pacific is projected to have fastest growth, owing to rapidly increasing healthcare infrastructure and increasing awareness amongst population, and growing medical tourism industry in developing nations such as China, and India in this region.
This report identifies the global lipid panel test market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global lipid panel test market.
This report segments global lipid panel test market on the basis of disease, end-user and regional market as follows:
Lipid Panel Test Market, By Disease: Hyperlipidemia, Hypertriglyceridemia, Familial Hypercholesterolemia, Hyperlipoproteinemia, Tangier Disease
Lipid Panel Test Market, By End-User: Home Based Testing Kits, Diagnostic Laboratories, Hospital)
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
This report identifies all the major companies operating in the lipid panel test market. Some of the major companies’ profiles in detail are as follows:
Avanti Polar Lipids, Inc.
Beckman Coulter, Inc.
F. Hoffmann-La Roche Ltd
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Lipid Panel Test Market– Market Forces
4.1.1. Growing prevalence of dyslipidemia, cardiovascular diseases, and hypertension
4.1.2. Increasing funding from governments to identify at-risk population and dyslipidemia diagnosis
4.3.1. Emerging economies
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Lipid Panel Test Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Lipid Panel Test Market, By Disease
6.3. familial hypercholesterolemia
6.5. tangier disease
7. Lipid Panel Test Market, By End-User
7.1. home based testing kits
7.2. diagnostic laboratories
7.4. others (CROs, Public Health Institutions)
8. Lipid Panel Test Market, By Geography
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.4. Rest of the World (RoW)
8.4.2. Rest of RoW
9. Lipid Panel Test – Market Entropy
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. Abbott Laboratories
10.2. Alere Inc.
10.3. Avanti Polar Lipids, Inc.
10.4. Beckman Coulter, Inc.
10.5. EuroMedixPOC nv/sa
10.6. F. Hoffmann-La Roche Ltd
10.7. PTS Diagnostics
10.8. Quest Diagnostics
10.9. Randox Laboratories Ltd.
10.10. Thermo Fisher Scientific Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights